Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands |
9 Months Ended |
Apr. 30, 2022 |
Apr. 30, 2021 |
| CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
| Net Income |
$ 423
|
$ 10,423
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
| Depreciation and amortization |
10,034
|
10,653
|
| Non-cash stock-based compensation |
2,267
|
1,849
|
| Deferred income taxes |
(1,311)
|
716
|
| Provision for bad debts and cash discounts |
(1)
|
(107)
|
| Loss on Impairment of Goodwill |
5,644
|
0
|
| Loss on impairment of patent applications |
323
|
0
|
| Loss on the disposals of property, plant and equipment |
346
|
10
|
| (Increase) Decrease in assets: |
|
|
| Accounts receivable |
(2,453)
|
(3,864)
|
| Inventories |
(11,456)
|
524
|
| Prepaid expenses |
181
|
(2,117)
|
| Other assets |
971
|
(1,066)
|
| Increase (Decrease) in liabilities: |
|
|
| Accounts payable |
1,333
|
(4,227)
|
| Accrued expenses |
1,120
|
(4,070)
|
| Deferred compensation |
556
|
602
|
| Pension and postretirement benefits |
(924)
|
(656)
|
| Other liabilities |
(1,593)
|
(330)
|
| Total Adjustments |
5,037
|
(2,083)
|
| Net Cash Provided by Operating Activities |
5,460
|
8,340
|
| CASH FLOWS FROM INVESTING ACTIVITIES |
|
|
| Capital expenditures |
(16,012)
|
(10,757)
|
| Proceeds from sale of property, plant, and equipment |
0
|
4
|
| Net Cash Used in Investing Activities |
(16,012)
|
(10,753)
|
| CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
| Proceeds from issuance of notes payable |
25,000
|
0
|
| Payments of debt issuance costs |
(114)
|
0
|
| Dividends paid |
(5,573)
|
(5,399)
|
| Purchase of treasury stock |
(10,506)
|
(2,925)
|
| Net Cash Provided by (Used in) Financing Activities |
8,807
|
(8,324)
|
| Effect of exchange rate changes on Cash and Cash Equivalents |
(21)
|
165
|
| Net Decrease in Cash and Cash Equivalents |
(1,766)
|
(10,572)
|
| Cash and Cash Equivalents, Beginning of Period |
24,591
|
40,890
|
| Cash and Cash Equivalents, End of Period |
22,825
|
30,318
|
| Supplemental disclosure of non-cash investing and financing activities: |
|
|
| Interest payments, net of amounts capitalized |
178
|
198
|
| Income tax payments |
219
|
1,482
|
| Capital expenditures accrued, but not paid |
1,071
|
751
|
| Cash dividends declared and accrued, but not paid |
$ 1,845
|
$ 1,795
|